Home › Epstein-Barr Virus Infections › Ohio › Columbus
Epstein-Barr Virus Infections clinical trials in Columbus, OH
4 studies for Epstein-Barr Virus Infections are looking for participants at sites in and around Columbus (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection
RecruitingPhase 2
- Nationwide Children's Hosptial, Columbus
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
RecruitingPhase 3
- Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (Adults and Pediatrics), Columbus
Third Party Viral Specific T-cells (VSTs)
RecruitingPhase 2
- The Ohio State University Wexner Medical Center - James Cancer Hospital, Columbus
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
RecruitingPhase 1/2
- The Ohio State University Comprehensive Cancer Center, Columbus
Epstein-Barr Virus Infections trials in other cities
Other studies in Columbus
- Non-Small Cell Lung Cancer57 studies
- Cancer (all types)40 studies
- Breast Cancer39 studies
- Ovarian Cancer39 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia34 studies
- Chronic Lymphocytic Leukemia29 studies
- Metastatic Cancer25 studies
- Multiple Myeloma25 studies
- Prostate Cancer25 studies
- Endometrial Cancer24 studies
- Colorectal Cancer24 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.